Polen Capital acquired 6.06 Thousand Charles River Laboratories International shares worth $1.27 Million. That's 0.00% of their equity portfolio (92nd largest holding). The first Charles River Laboratories International trade was made in Q2 2022. Since then Polen Capital bought shares three more times and sold shares on four occasions. The investor's estimated purchase price is $1.4 Million, resulting in a loss of 9.4%.
Charles River Laboratories (CRL) has sold its Avian Vaccine Services business to private equity firm Arlington Capital Partners.The business, now AVS Bio, wi...
Seeking Alpha, over 1 year agoZero NPLs on Rs. 14 Billion worth loans in a globally challenging year Colombo, June 30, 2021 Softlogic Finance PLC, a subsidiary of Softlogic Capital the f...
Lanka Business News, almost 3 years ago